CC

Casdin Capital Portfolio holdings

AUM $1.1B
1-Year Est. Return 24.98%
This Quarter Est. Return
1 Year Est. Return
+24.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.22B
AUM Growth
-$272M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
46
New
Increased
Reduced
Closed

Top Buys

1
+$10.9M
2
+$10.4M
3
+$8.07M
4
HIMS icon
Hims & Hers Health
HIMS
+$5.91M
5
LAB icon
Standard BioTools
LAB
+$5.21M

Top Sells

1
+$12.3M
2
+$11M
3
+$10.6M
4
FDMT icon
4D Molecular Therapeutics
FDMT
+$6.41M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
26
Agios Pharmaceuticals
AGIO
$2.52B
$7.33M 0.6%
250,000
MRNA icon
27
Moderna
MRNA
$10.6B
$6.38M 0.52%
225,000
+50,000
HIMS icon
28
Hims & Hers Health
HIMS
$10.3B
$5.91M 0.48%
+200,000
TNYA icon
29
Tenaya Therapeutics
TNYA
$235M
$3.84M 0.31%
6,732,971
VSTM icon
30
Verastem
VSTM
$582M
$3.62M 0.3%
+600,000
SEPN
31
Septerna Inc
SEPN
$918M
$3.2M 0.26%
553,268
SLDB icon
32
Solid Biosciences
SLDB
$420M
$2.87M 0.23%
+775,000
ABSI icon
33
Absci
ABSI
$640M
$2.44M 0.2%
973,260
TDOC icon
34
Teladoc Health
TDOC
$1.53B
$2.39M 0.2%
+300,000
IPSC icon
35
Century Therapeutics
IPSC
$50.4M
$1.53M 0.12%
3,212,316
-1,978,190
DYN icon
36
Dyne Therapeutics
DYN
$3.21B
$1.05M 0.09%
+100,000
CTNM
37
Contineum Therapeutics
CTNM
$321M
$1.04M 0.08%
148,333
-148,333
RXRX icon
38
Recursion Pharmaceuticals
RXRX
$2.41B
$875K 0.07%
165,323
PACB icon
39
Pacific Biosciences
PACB
$703M
$854K 0.07%
723,767
-312,092
PRME icon
40
Prime Medicine
PRME
$881M
$731K 0.06%
367,175
GLUE icon
41
Monte Rosa Therapeutics
GLUE
$794M
$399K 0.03%
86,014
DNA icon
42
Ginkgo Bioworks
DNA
$769M
$208K 0.02%
36,493
TNGX icon
43
Tango Therapeutics
TNGX
$1.07B
$171K 0.01%
125,000
-1,063,349
KRON
44
DELISTED
Kronos Bio
KRON
$102K 0.01%
123,839
FDMT icon
45
4D Molecular Therapeutics
FDMT
$537M
– –
-1,150,000
FTRE icon
46
Fortrea Holdings
FTRE
$950M
– –
-275,000
1
2